As of 3:59pm ET
| -0.01 / -0.05%|
The 2 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 60.00, with a high estimate of 70.00 and a low estimate of 50.00. The median estimate represents a +216.29% increase from the last price of 18.97.
The current consensus among 3 polled investment analysts is to Buy stock in Acer Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.